Literature DB >> 11562466

Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes.

I Taddei1, M Morishima, T Huynh, E A Lindsay.   

Abstract

The del22q11 syndrome is associated with a highly variable phenotype despite the uniformity of the chromosomal deletion that causes the disease in most patients. Df1/+ mice, which model del22q11, present with reduced penetrance of cardiovascular defects similar to those seen in deleted patients but not with other del22q11-like findings. The reduced penetrance of cardiovascular defects is caused by the ability of mutant embryos to recover from a fourth pharyngeal arch artery growth abnormality that is fully penetrant in early embryos. Here we show that genetic background has a major effect on penetrance of cardiovascular defects by affecting this embryonic recovery process. This effect could not be explained by allelic variation at the haploid locus, and it is likely to be caused by genetic modifiers elsewhere in the genome. We also show that genetic factors control extension of the Df1/+ phenotype to include thymic and parathyroid anomalies, establishing the Df1 mouse as a model for the genetic analysis of three major features of human del22q11 syndrome. We found that in Df1/+ mice, as in human patients, expression of the heart and thymic phenotypes are essentially independent from each other, suggesting that they may be controlled by different genetic modifiers. These data provide a framework for our understanding of phenotypic variability in patients with del22q11 syndrome and the tools for its genetic dissection.

Entities:  

Mesh:

Year:  2001        PMID: 11562466      PMCID: PMC58746          DOI: 10.1073/pnas.201127298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Phenotypic discordance in monozygotic twins with 22q11.2 deletion.

Authors:  H Yamagishi; C Ishii; J Maeda; Y Kojima; R Matsuoka; M Kimura; A Takao; K Momma; N Matsuo
Journal:  Am J Med Genet       Date:  1998-07-24

3.  Comparative mapping of the human 22q11 chromosomal region and the orthologous region in mice reveals complex changes in gene organization.

Authors:  A Puech; B Saint-Jore; B Funke; D J Gilbert; H Sirotkin; N G Copeland; N A Jenkins; R Kucherlapati; B Morrow; A I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome.

Authors:  L Edelmann; R K Pandita; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

5.  Monozygotic twins with chromosome 22q11 deletion and discordant phenotype.

Authors:  J Goodship; I Cross; P Scambler; J Burn
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

6.  A common molecular basis for rearrangement disorders on chromosome 22q11.

Authors:  L Edelmann; R K Pandita; E Spiteri; B Funke; R Goldberg; N Palanisamy; R S Chaganti; E Magenis; R J Shprintzen; B E Morrow
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

7.  22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes.

Authors:  M C Vincent; F Heitz; J Tricoire; G Bourrouillou; E Kuhlein; M Rolland; P Calvas
Journal:  Genet Couns       Date:  1999

8.  Cloning and comparative mapping of the DiGeorge syndrome critical region in the mouse.

Authors:  H F Sutherland; U J Kim; P J Scambler
Journal:  Genomics       Date:  1998-08-15       Impact factor: 5.736

9.  Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.

Authors:  E A Lindsay; R Goldberg; V Jurecic; B Morrow; C Carlson; R S Kucherlapati; R J Shprintzen; A Baldini
Journal:  Am J Med Genet       Date:  1995-07-03

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  22 in total

1.  Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.

Authors:  Katrina Prescott; Sarah Ivins; Mike Hubank; Elizabeth Lindsay; Antonio Baldini; Peter Scambler
Journal:  Hum Genet       Date:  2005-03-19       Impact factor: 4.132

2.  Evaluation of potential modifiers of the palatal phenotype in the 22q11.2 deletion syndrome.

Authors:  Deborah A Driscoll; Torrey Boland; Beverly S Emanuel; Richard E Kirschner; Don LaRossa; Jeanne Manson; Donna McDonald-McGinn; Peter Randall; Cynthia Solot; Elaine Zackai; Laura E Mitchell
Journal:  Cleft Palate Craniofac J       Date:  2006-07

3.  Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm.

Authors:  Amélie Calmont; Sarah Ivins; Kelly Lammerts Van Bueren; Irinna Papangeli; Vanessa Kyriakopoulou; William D Andrews; James F Martin; Anne M Moon; Elizabeth A Illingworth; M Albert Basson; Peter J Scambler
Journal:  Development       Date:  2009-09       Impact factor: 6.868

Review 4.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 5.  22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia.

Authors:  Maria Karayiorgou; Tony J Simon; Joseph A Gogos
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

6.  Diagnosis of Fanconi anemia by diepoxybutane analysis.

Authors:  Arleen D Auerbach
Journal:  Curr Protoc Hum Genet       Date:  2015-04-01

7.  Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome.

Authors:  Lucile Ryckebüsch; Nicolas Bertrand; Karim Mesbah; Fanny Bajolle; Karen Niederreither; Robert G Kelly; Stéphane Zaffran
Journal:  Circ Res       Date:  2010-01-28       Impact factor: 17.367

Review 8.  Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia.

Authors:  Tadao Arinami
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

Review 9.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

10.  Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome.

Authors:  Kelly Lammerts van Bueren; Irinna Papangeli; Francesca Rochais; Kerra Pearce; Catherine Roberts; Amelie Calmont; Dorota Szumska; Robert G Kelly; Shoumo Bhattacharya; Peter J Scambler
Journal:  Dev Biol       Date:  2010-02-01       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.